Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 63 Breast 46 Thoracic 44 Gynecologic 34 Genitourinary 28 Tumor-Agnostic 25 Other hematologic neoplasm 24 Lymphoid 23 Head & Neck 21 CNS 21 Dermatologic 16 Sarcoma 12 Plasma cell 9 Myeloid 5 Other solid neoplasm 3 NET 1 Endocrine 1 Classical hematology 1

Conditions

Midgut Neuroendocrine Tumors 1

Interventions

Eating 5 Standard of Care 4 Radiofrequency Ablation 4 Exercise 4 Surgical Procedures, Operative 3 Radiosurgery 3 Endoscopic Mucosal Resection 3 Adrenalectomy 3 lutetium Lu 177 dotatate 2 Yoga 2 Saline Solution 2 Robotic Surgical Procedures 2 Resistance Training 2 Proton Therapy 2 Propofol 2 Palliative Care 2 Octreotide 2 Magnetic Resonance Imaging 2 Lutetium-177 2 Liquid Biopsy 2 Interviews as Topic 2 Hydrocortisone 2 Diet, Mediterranean 2 Diet 2 Desflurane 2 Data Collection 2 Conversion to Open Surgery 2 Control Groups 2 Calcium 2 3-Iodobenzylguanidine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Blood Specimen Collection × Endocrine × Clear all

NCT03667092 2025-04-10

GENEBIOLuNET

University Hospital, Toulouse

Phase NA Completed

Midgut Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡